PDB33 COST-EFFECTIVENESS OF THE PDM-PROVALUE STUDY PROGRAM IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM THE GERMAN STATUTORY HEALTHCARE PERSPECTIVE
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.915
https://www.valueinhealthjournal.com/article/S1098-3015(19)33293-0/fulltext
Title :
PDB33 COST-EFFECTIVENESS OF THE PDM-PROVALUE STUDY PROGRAM IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM THE GERMAN STATUTORY HEALTHCARE PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33293-0&doi=10.1016/j.jval.2019.09.915
First page :
Section Title :
Open access? :
No
Section Order :
10809